Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Britannia Life Sciences Inc Com C.RLSC

Healthcare Drug Manufacturers - Major Cannabis
RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category. It derives key revenue from the United States.


CSE:RLSC - Post by User

Britannia Life Sciences Inc Com > Info
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by BluHorseshoeon Jan 04, 2021 8:53pm
178 Views
Post# 32221170

RE:Info

RE:InfoSame boat as you my friend. Looks like another deal that went south..

It would be nice to get some closure on this soon. Maybe if shareholders/bag holders make an effort to contact him he'll at least have the courtesy to break the news.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities